ARQT · Forms 3, 4, 5
Insider trades at Arcutis Biotherapeutics, Inc.
1 insider sold $127K of Arcutis Biotherapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Arcutis Biotherapeutics, Inc. (ARQT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Howard G. Welgus | Director | Option exercise | 822 | $6.52 | $5K | Form 4 | |
| Howard G. Welgus | Director | Option exercise | 1,018 | $7.51 | $8K | Form 4 | |
| Howard G. Welgus | Director | Option exercise | 2,254 | $8.63 | $19K | Form 4 | |
| Howard G. Welgus | Director | Sell (10b5-1 plan) | 4,728 | $26.93 | $127K | Form 4 | |
| Masaru Matsuda | EVP, Chief Legal Officer | Sell (10b5-1 plan) | 3,674 | $25.00 | $92K | Form 4 | |
| Howard G. Welgus | Director | Option exercise | 822 | $6.52 | $5K | Form 4 | |
| Howard G. Welgus | Director | Option exercise | 1,019 | $7.51 | $8K | Form 4 | |
| Howard G. Welgus | Director | Option exercise | 2,255 | $8.63 | $19K | Form 4 | |
| Howard G. Welgus | Director | Sell (10b5-1 plan) | 4,730 | $24.18 | $114K | Form 4 | |
| Masaru Matsuda | EVP, Chief Legal Officer | Sell (10b5-1 plan) | 9,989 | $25.03 | $250K | Form 4 | |
| Terrie Curran | Director | Option exercise | 11,148 | $7.51 | $84K | Form 4 | |
| Terrie Curran | Director | Sell | 11,148 | $25.03 | $279K | Form 4 | |
| Terrie Curran | Director | Option exercise | 27,052 | $8.63 | $233K | Form 4 | |
| Terrie Curran | Director | Sell | 27,052 | $25.03 | $677K | Form 4 | |
| Terrie Curran | Director | Option exercise | 1,072 | $7.51 | $8K | Form 4 | |
| Terrie Curran | Director | Sell | 1,072 | $26.04 | $28K | Form 4 | |
| Patrick Burnett | EVP, Chief Medical Officer | Sell | 1,697 | $27.00 | $46K | Form 4 | |
| Howard G. Welgus | Director | Option exercise | 822 | $6.52 | $5K | Form 4 | |
| Howard G. Welgus | Director | Option exercise | 1,019 | $7.51 | $8K | Form 4 | |
| Howard G. Welgus | Director | Option exercise | 2,255 | $8.63 | $19K | Form 4 | |
| Howard G. Welgus | Director | Sell (10b5-1 plan) | 4,730 | $26.18 | $124K | Form 4 | |
| Patrick Burnett | EVP, Chief Medical Officer | Option exercise | 6,700 | $3.64 | $24K | Form 4 | |
| Patrick Burnett | EVP, Chief Medical Officer | Sell | 6,700 | $26.08 | $175K | Form 4 | |
| Patrick Burnett | EVP, Chief Medical Officer | Option exercise | 8,300 | $3.64 | $30K | Form 4 | |
| Patrick Burnett | EVP, Chief Medical Officer | Sell | 8,300 | $26.52 | $220K | Form 4 | |
| Patrick Burnett | EVP, Chief Medical Officer | Sell (10b5-1 plan) | 955 | $26.12 | $25K | Form 4 | |
| Masaru Matsuda | EVP, Chief Legal Officer | Sell (10b5-1 plan) | 1,230 | $26.12 | $32K | Form 4 | |
| Todd Watanabe | President and Chief Executive Officer | Sell (10b5-1 plan) | 4,375 | $26.12 | $114K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.